Show simple item record

dc.contributor.authorJafri, Rabab Z
dc.contributor.authorAli, Asad
dc.contributor.authorMessonnier, Nancy E
dc.contributor.authorTevi-Benissan, Carol
dc.contributor.authorDurrheim, David
dc.contributor.authorEskola, Juhani
dc.contributor.authorFermon, Florence
dc.contributor.authorKlugman, Keith P
dc.contributor.authorRamsay, Mary
dc.contributor.authorSow, Samba
dc.contributor.authorZhujun, Shao
dc.contributor.authorBhutta, Zulfiqar A
dc.contributor.authorAbramson, Jon
dc.date.accessioned2013-09-24T20:49:44Z
dc.date.available2013-09-24T20:49:44Z
dc.date.issued2013-09-10
dc.date.submitted2013-09-18
dc.identifier.citationGlobal epidemiology of invasive meningococcal disease 2013, 11 (1):17 Population Health Metricsen_GB
dc.identifier.issn1478-7954
dc.identifier.doi10.1186/1478-7954-11-17
dc.identifier.urihttp://hdl.handle.net/10144/302226
dc.description.abstractNeisseria meningitidis is one of the leading causes of bacterial meningitis globally and can also cause sepsis, pneumonia, and other manifestations. In countries with high endemic rates, the disease burden places an immense strain on the public health system. The worldwide epidemiology of invasive meningococcal disease (IMD) varies markedly by region and over time. This review summarizes the burden of IMD in different countries and identifies the highest-incidence countries where routine preventive programs against Neisseria meningitidis would be most beneficial in providing protection. Available epidemiological data from the past 20 years in World Health Organization and European Centre for Disease Prevention and Control collections and published articles are included in this review, as well as direct communications with leading experts in the field. Countries were grouped into high-, moderate-, and low-incidence countries. The majority of countries in the high-incidence group are found in the African meningitis belt; many moderate-incidence countries are found in the European and African regions, and Australia, while low-incidence countries include many from Europe and the Americas. Priority countries for vaccine intervention are high- and moderate-incidence countries where vaccine-preventable serogroups predominate. Epidemiological data on burden of IMD are needed in countries where this is not known, particularly in South- East Asia and Eastern Mediterranean regions, so evidence-based decisions about the use of meningococcal vaccines can be made.
dc.language.isoenen
dc.publisherBioMed Centralen_GB
dc.relation.urlhttp://www.pophealthmetrics.com/content/11/1/17en_GB
dc.rightsArchived with thanks to Population Health Metricsen_GB
dc.subjectMeningitisen_GB
dc.titleGlobal epidemiology of invasive meningococcal diseaseen
dc.identifier.journalPopulation Health Metricsen_GB
refterms.dateFOA2019-03-04T10:46:36Z
html.description.abstractNeisseria meningitidis is one of the leading causes of bacterial meningitis globally and can also cause sepsis, pneumonia, and other manifestations. In countries with high endemic rates, the disease burden places an immense strain on the public health system. The worldwide epidemiology of invasive meningococcal disease (IMD) varies markedly by region and over time. This review summarizes the burden of IMD in different countries and identifies the highest-incidence countries where routine preventive programs against Neisseria meningitidis would be most beneficial in providing protection. Available epidemiological data from the past 20 years in World Health Organization and European Centre for Disease Prevention and Control collections and published articles are included in this review, as well as direct communications with leading experts in the field. Countries were grouped into high-, moderate-, and low-incidence countries. The majority of countries in the high-incidence group are found in the African meningitis belt; many moderate-incidence countries are found in the European and African regions, and Australia, while low-incidence countries include many from Europe and the Americas. Priority countries for vaccine intervention are high- and moderate-incidence countries where vaccine-preventable serogroups predominate. Epidemiological data on burden of IMD are needed in countries where this is not known, particularly in South- East Asia and Eastern Mediterranean regions, so evidence-based decisions about the use of meningococcal vaccines can be made.


Files in this item

Thumbnail
Name:
Jafri et al. - 2013 - Global ...
Size:
278.4Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record